Laval, Quebec – December 15, 2022 – The team at Group Elite is proud to announce that their recent campaign raised over $72,000 for the SickKids Foundation, in support of a retinoblastoma clinical trial led by The Hospital for Sick Children (SickKids). As part of their 10-Year Anniversary celebration, Group Elite created a campaign called, “We Have the Power” to raise money to support retinoblastoma research. The campaign had an initial goal of $10,000 and generous donations from employees and global partners were made in Canada and the United States.
“The generosity of our extended Group Elite family astounds me,” shared Michael Moore, President and CEO of Group Elite. “Through personal gifts and donated vacation days, we are proud to support the remarkable team at SickKids with these contributions.”
For over 3 years, the Group Elite team continues an indirect relationship with a special girl from Montreal named Ella suffering from retinoblastoma. Retinoblastoma is a rare but devastating form of childhood cancer affecting the retina at the back of the eye, and Ella’s treatment requires the care of a multidisciplinary team of paediatric oncologists and ophthalmologists. Recently a new treatment option designed to kill the tumour cells and preserve vision was made possible through a clinical trial led by Dr. Brenda Gallie, Ophthalmologist in the Department of Ophthalmology and Vision Sciences at SickKids. The trial findings may provide a step toward new treatment options for patients with retinoblastoma.
SickKids, affiliated with the University of Toronto, is one of Canada's most research-intensive hospitals and the largest centre dedicated to improving children's health in the country. SickKids also plays a crucial role as an international referral centre for treating retinoblastoma patients.
Gifts to the SickKids Foundation can still be made on the “We Have the Power” website at https://www.grouplelite.com/sickkids.
Posted on PR Web at: http://www.prweb.com/releases/2022/12/prweb19076880.htm